位置:首页 > 蛋白库 > REPS1_MOUSE
REPS1_MOUSE
ID   REPS1_MOUSE             Reviewed;         795 AA.
AC   O54916; Q3UAM3; Q5PPQ9; Q8C9J9; Q99LR8;
DT   15-AUG-2003, integrated into UniProtKB/Swiss-Prot.
DT   03-NOV-2009, sequence version 2.
DT   03-AUG-2022, entry version 174.
DE   RecName: Full=RalBP1-associated Eps domain-containing protein 1;
DE   AltName: Full=RalBP1-interacting protein 1;
GN   Name=Reps1;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4), AND CHARACTERIZATION.
RC   TISSUE=Muscle;
RX   PubMed=9395447; DOI=10.1074/jbc.272.50.31230;
RA   Yamaguchi A., Urano T., Goi T., Feig L.A.;
RT   "An eps homology (EH) domain protein that binds to the ral-GTPase target,
RT   RalBP1.";
RL   J. Biol. Chem. 272:31230-31234(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 39-795 (ISOFORM 1).
RC   STRAIN=C57BL/6J; TISSUE=Bone marrow, and Thymus;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 499-795 (ISOFORM 1).
RC   TISSUE=Embryo, and Mammary tumor;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-272, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=17242355; DOI=10.1073/pnas.0609836104;
RA   Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.;
RT   "Large-scale phosphorylation analysis of mouse liver.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-708, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19144319; DOI=10.1016/j.immuni.2008.11.006;
RA   Trost M., English L., Lemieux S., Courcelles M., Desjardins M.,
RA   Thibault P.;
RT   "The phagosomal proteome in interferon-gamma-activated macrophages.";
RL   Immunity 30:143-154(2009).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-272; SER-273; SER-539 AND
RP   THR-543, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Brown adipose tissue, Heart, Kidney, Liver, Lung, Pancreas,
RC   Spleen, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [8]
RP   STRUCTURE BY NMR OF 279-370.
RX   PubMed=11389591; DOI=10.1021/bi002700m;
RA   Kim S., Cullis D.N., Feig L.A., Baleja J.D.;
RT   "Solution structure of the Reps1 EH domain and characterization of its
RT   binding to NPF target sequences.";
RL   Biochemistry 40:6776-6785(2001).
CC   -!- FUNCTION: May coordinate the cellular actions of activated EGF
CC       receptors and Ral-GTPases.
CC   -!- SUBUNIT: Homodimer (Potential). Interacts with RALBP1, CRK and GRB2.
CC       Binding to RALBP1 does not affect its Ral-binding activity. Forms a
CC       complex with the SH3 domains of CRK and GRB2 which may link it to an
CC       EGF-responsive tyrosine kinase. Interacts with RAB11FIP2 (By
CC       similarity). Interacts with AMPH, ITSN1 (via SH3 domains) and SGIP1;
CC       may be involved in clathrin-mediated endocytosis (By similarity).
CC       {ECO:0000250, ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Membrane, clathrin-coated pit {ECO:0000250}.
CC       Note=Colocalize with ITSN1 at the plasma membrane in structures that
CC       are most probably clathrin-coated pits. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=O54916-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O54916-2; Sequence=VSP_038337, VSP_007956, VSP_007957;
CC       Name=3;
CC         IsoId=O54916-3; Sequence=VSP_038336, VSP_038338;
CC       Name=4;
CC         IsoId=O54916-4; Sequence=VSP_038336;
CC   -!- TISSUE SPECIFICITY: Expressed in all tissues examined. The highest
CC       level expression was found in the kidney and testis.
CC   -!- PTM: EGF stimulates phosphorylation on Tyr-residues.
CC   -!- MISCELLANEOUS: [Isoform 2]: Due to intron retention. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAE29439.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAE30291.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF031939; AAB94736.1; -; mRNA.
DR   EMBL; AK150284; BAE29439.1; ALT_INIT; mRNA.
DR   EMBL; AK151309; BAE30291.1; ALT_INIT; mRNA.
DR   EMBL; AK041967; BAC31117.1; -; mRNA.
DR   EMBL; AC153433; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC002256; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BC087547; AAH87547.1; -; mRNA.
DR   CCDS; CCDS23710.2; -. [O54916-1]
DR   PIR; T09173; T09173.
DR   RefSeq; NP_001104535.1; NM_001111065.1.
DR   RefSeq; NP_033074.2; NM_009048.2. [O54916-1]
DR   PDB; 1FI6; NMR; -; A=279-370.
DR   PDBsum; 1FI6; -.
DR   AlphaFoldDB; O54916; -.
DR   BMRB; O54916; -.
DR   SMR; O54916; -.
DR   BioGRID; 202861; 13.
DR   CORUM; O54916; -.
DR   IntAct; O54916; 2.
DR   STRING; 10090.ENSMUSP00000123238; -.
DR   iPTMnet; O54916; -.
DR   PhosphoSitePlus; O54916; -.
DR   EPD; O54916; -.
DR   jPOST; O54916; -.
DR   MaxQB; O54916; -.
DR   PaxDb; O54916; -.
DR   PeptideAtlas; O54916; -.
DR   PRIDE; O54916; -.
DR   ProteomicsDB; 255283; -. [O54916-1]
DR   ProteomicsDB; 255284; -. [O54916-2]
DR   ProteomicsDB; 255285; -. [O54916-3]
DR   ProteomicsDB; 255286; -. [O54916-4]
DR   Antibodypedia; 33064; 119 antibodies from 25 providers.
DR   Ensembl; ENSMUST00000126390; ENSMUSP00000123238; ENSMUSG00000019854. [O54916-1]
DR   GeneID; 19707; -.
DR   KEGG; mmu:19707; -.
DR   UCSC; uc007ema.2; mouse. [O54916-1]
DR   CTD; 85021; -.
DR   MGI; MGI:1196373; Reps1.
DR   VEuPathDB; HostDB:ENSMUSG00000019854; -.
DR   eggNOG; KOG1955; Eukaryota.
DR   GeneTree; ENSGT00940000158749; -.
DR   HOGENOM; CLU_014864_0_0_1; -.
DR   InParanoid; O54916; -.
DR   OMA; QCCDVEN; -.
DR   OrthoDB; 1319710at2759; -.
DR   PhylomeDB; O54916; -.
DR   TreeFam; TF316546; -.
DR   Reactome; R-MMU-8856825; Cargo recognition for clathrin-mediated endocytosis.
DR   Reactome; R-MMU-8856828; Clathrin-mediated endocytosis.
DR   BioGRID-ORCS; 19707; 2 hits in 72 CRISPR screens.
DR   ChiTaRS; Reps1; mouse.
DR   EvolutionaryTrace; O54916; -.
DR   PRO; PR:O54916; -.
DR   Proteomes; UP000000589; Chromosome 10.
DR   RNAct; O54916; protein.
DR   Bgee; ENSMUSG00000019854; Expressed in undifferentiated genital tubercle and 260 other tissues.
DR   ExpressionAtlas; O54916; baseline and differential.
DR   Genevisible; O54916; MM.
DR   GO; GO:0005905; C:clathrin-coated pit; ISO:MGI.
DR   GO; GO:0005886; C:plasma membrane; ISO:MGI.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0017124; F:SH3 domain binding; ISO:MGI.
DR   GO; GO:0006897; P:endocytosis; IBA:GO_Central.
DR   GO; GO:0016197; P:endosomal transport; IBA:GO_Central.
DR   GO; GO:0006898; P:receptor-mediated endocytosis; IEA:InterPro.
DR   CDD; cd00052; EH; 1.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR000261; EH_dom.
DR   InterPro; IPR026814; Reps1.
DR   PANTHER; PTHR11216:SF63; PTHR11216:SF63; 1.
DR   Pfam; PF12763; EF-hand_4; 1.
DR   SMART; SM00027; EH; 2.
DR   SUPFAM; SSF47473; SSF47473; 2.
DR   PROSITE; PS00018; EF_HAND_1; 1.
DR   PROSITE; PS50222; EF_HAND_2; 1.
DR   PROSITE; PS50031; EH; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Coated pit; Coiled coil;
KW   Membrane; Metal-binding; Phosphoprotein; Reference proteome; Repeat.
FT   CHAIN           1..795
FT                   /note="RalBP1-associated Eps domain-containing protein 1"
FT                   /id="PRO_0000073830"
FT   DOMAIN          10..113
FT                   /note="EH 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00077"
FT   DOMAIN          285..374
FT                   /note="EH 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00077"
FT   DOMAIN          318..353
FT                   /note="EF-hand"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   REGION          112..238
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          380..433
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          469..720
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          651..795
FT                   /note="Interaction with RALBP1"
FT   COILED          750..790
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        112..127
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        214..238
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        401..433
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        475..540
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        541..555
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        556..578
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        583..597
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        609..642
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        643..657
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        664..690
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        702..720
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         331
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         333
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         335
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         342
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   MOD_RES         145
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96D71"
FT   MOD_RES         162
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96D71"
FT   MOD_RES         166
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96D71"
FT   MOD_RES         170
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96D71"
FT   MOD_RES         173
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96D71"
FT   MOD_RES         272
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17242355,
FT                   ECO:0007744|PubMed:21183079"
FT   MOD_RES         273
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         288
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         307
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96D71"
FT   MOD_RES         475
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96D71"
FT   MOD_RES         482
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96D71"
FT   MOD_RES         489
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96D71"
FT   MOD_RES         539
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         543
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         561
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96D71"
FT   MOD_RES         708
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19144319"
FT   MOD_RES         739
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96D71"
FT   VAR_SEQ         1..244
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:16141072"
FT                   /id="VSP_038337"
FT   VAR_SEQ         1..52
FT                   /note="Missing (in isoform 3 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:9395447"
FT                   /id="VSP_038336"
FT   VAR_SEQ         420..454
FT                   /note="QWETFSERSSSSQTLTQFDSNIAPADPDTAIVHPV -> VSKTSLSLLEISL
FT                   FTGRSFKQDRFTAGYLQYAHTP (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:16141072"
FT                   /id="VSP_007956"
FT   VAR_SEQ         420..446
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_038338"
FT   VAR_SEQ         455..795
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:16141072"
FT                   /id="VSP_007957"
FT   CONFLICT        161
FT                   /note="V -> A (in Ref. 1; AAB94736)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        605
FT                   /note="D -> N (in Ref. 2; BAE29439)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        701
FT                   /note="P -> T (in Ref. 2; BAE29439)"
FT                   /evidence="ECO:0000305"
FT   HELIX           283..293
FT                   /evidence="ECO:0007829|PDB:1FI6"
FT   TURN            294..296
FT                   /evidence="ECO:0007829|PDB:1FI6"
FT   STRAND          303..305
FT                   /evidence="ECO:0007829|PDB:1FI6"
FT   HELIX           306..316
FT                   /evidence="ECO:0007829|PDB:1FI6"
FT   HELIX           320..330
FT                   /evidence="ECO:0007829|PDB:1FI6"
FT   STRAND          335..339
FT                   /evidence="ECO:0007829|PDB:1FI6"
FT   HELIX           340..355
FT                   /evidence="ECO:0007829|PDB:1FI6"
SQ   SEQUENCE   795 AA;  86519 MW;  98D788160F560509 CRC64;
     MEGLTLSDAE QKYYSDLFSY CDIESTKKVV VNGRVLELFR AAQLPNDVVL QIMELCGATR
     LGYFGRSQFY IALKLVAVAQ SGFPLRVESI NTVKDLPLPR FVASKNEQES RLAASYSSDS
     ENQGSYSGVI PPPPGRGQVK KGPGSHDAVQ PRPSAEQQEP VSPVVSPQQS PPTSPHTWRK
     HSRHPSGGNS ERPLTGPGPF WSPFGDAQAG SSAGDAVWSG QSPPPPQDNW VSFADTPPTS
     ALLTMHPASV QDQTTVRTVA SAATANEIRR QSSSYEDPWK ITDEQRQYYV NQFKTIQPDL
     NGFIPGSAAK EFFTKSKLPI LELSHIWELS DFDKDGALTL DEFCAAFHLV VARKNGYDLP
     EKLPESLMPK LIDLEDSADV GEQPGEVGYS GSPAEAPPSK SPSMPSLNQT WPELNQSSEQ
     WETFSERSSS SQTLTQFDSN IAPADPDTAI VHPVPIRMTP SKIHMQEMEL KRTSSDHTNP
     TSPLLVKPSD LSEENKINSS VKFPSGNTVD GYSSSDSFPS DPEQIGSSVT RQRSHSGTSP
     DNTAPPPPPP RPQPSHSRSS SLDMNRTFAV TTGQQQAGVV AHPPAVPPRP QPSQAPGPSV
     HRPVDADGLI THTSTSPQQI PEQPNFADFS QFEVFAASNV SEEQDSEAEK HPEVLPAEKA
     SDPSSSLRAA QADSKAEEKT ATNVPANVSK GTTPLAPPPK PVRRRLKSED ELRPDVDEHT
     QKTGVLAAVL TSQPSIPRSV GKDKKAIQAS IRRNKETNTV LARLNSELQQ QLKDVLEERI
     SLEVQLEQLR PFSHL
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024